ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2119

Wogonin, a Plant-Derived Flavonoid, Exert Anti-Inflammatory and Chondroprotective Effects through the Activation Nrf2/HO-1 Signaling in Human OA Chondrocytes

Mohammad N. Khan, Abdul Haseeb, Sara Haynie and Tariq M Haqqi, Anatomy & Neurobiology, Northeast Ohio Medical University, Rootstown, OH

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: chondrocytes, inflammation and osteoarthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 15, 2016

Title: Biology and Pathology of Bone and Joint - Poster I

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:   Osteoarthritis (OA), characterized by progressive destruction of articular cartilage, is the most common form of human arthritis. Wogonin is a naturally occurring flavonoid found in root extract of Scutellaria baicalensis, and it has been shown to exhibit diverse biological activities. Here, we evaluated the potential anti-inflammatory and chondroprotective effects of Wogonin in IL-1β stimulated human OA chondrocytes.

Methods:   Primary human OA chondrocytes were isolated by enzymatic digestion of the cartilage obtained from OA patients who underwent total knee arthroplasty at Crystal Clinic, Akron, Ohio. Effect of Wogonin on IL-1β-induced mRNA and protein expression of iNOS, COX2, IL-6, MMP-3, MMP-9, MMP-13, ADAMTS4, ACAN and COL2A1 was examined by Taqman Gene expression assays and immunoblotting, respectively. Estimation of NO in culture supernatant was done using Griess assay. PGE2 in culture supernatant was quantified by ELISA. Protein levels of nuclear factor (erythroid-derived 2)-like 2 (Nrf2), heme-oxygenase-1 (HO-1), and the total protein levels and phosphorylation of MAPKs were assayed by immunoblotting. siRNA mediated knockdown was used to deplete target protein. Cellular uptake of Wogonin in OA chondrocytes was quantified by MRM analysis using mass-spectrometry.

Results:   Wogonin completely suppressed the IL-1β-induced mRNA and protein expression of COX2, IL-6, iNOS, MMP-3, MMP-9, MMP-13, and ADAMTS-4 in human OA chondrocytes. Further, Wogonin significantly inhibited the NO and PGE2 production in IL-1β-stimulated human OA chondrocytes. Interestingly, Wogonin treatment increased the expression of type II collagen (COL2A1) and aggrecan (ACAN) in IL-1β-treated OA chondrocytes. Wogonin modulated the expression of IL-1β-induced phosphorylation of MAPKs (ERK1/2, JNK, and P38) in OA chondrocytes. Additionally, Wogonin activated redox sensitive transcription factor Nrf2, which has been shown to possess major chondroprotective role. Further, Wogonin upregulated the expression of Nrf2-dependent cytoprotective gene HO-1 in human OA chondrocytes. Inhibition of activity or knockdown of HO-1 expression abrogated the chondroprotective effect of Wogonin in IL-1β-stimulated human OA chondrocytes. Cellular uptake studies showed that Wogonin levels increased in a time dependent manner indicating the absence of metabolism of Wogonin in human OA chondrocytes. These data indicate that increased intracellular accumulation in due course of time activate Nrf2/HO-1 axis that may be responsible for the observed anti-inflammatory and chondroprotective activity of Wogonin under pathological conditions.

Conclusion:   The present study suggests that Wogonin could be an effective chondroprotective and anti-inflammatory agent as it switched the chondrocyte gene expression from catabolic towards anabolic response and this effect was mediated, at least in part by the activation of Nrf2 and upregulation of HO-1 expression in OA chondrocytes.


Disclosure: M. N. Khan, None; A. Haseeb, None; S. Haynie, None; T. M. Haqqi, None.

To cite this abstract in AMA style:

Khan MN, Haseeb A, Haynie S, Haqqi TM. Wogonin, a Plant-Derived Flavonoid, Exert Anti-Inflammatory and Chondroprotective Effects through the Activation Nrf2/HO-1 Signaling in Human OA Chondrocytes [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/wogonin-a-plant-derived-flavonoid-exert-anti-inflammatory-and-chondroprotective-effects-through-the-activation-nrf2ho-1-signaling-in-human-oa-chondrocytes/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/wogonin-a-plant-derived-flavonoid-exert-anti-inflammatory-and-chondroprotective-effects-through-the-activation-nrf2ho-1-signaling-in-human-oa-chondrocytes/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology